@IPOBoutique

We offer ratings, research and color for IPOs and secondary offerings. Our team has more than 50 years of experience in this arena.

 Tampa, FL & Houston, TX
IPOBoutique.com
Joined October 2010
  • Tweets12.3K
  • Following210
  • Followers15.4K
5.1KMedia
City Therapeutics, Inc. (CTY) priced 11.1mm shares (upsized from 9.72mm) at $18.00 (midpoint of range) and will debut on Friday. #IPO $CTY
4
1,062
Iambic Therapeutics, Inc. (IAM)  priced a full size deal of 9.375mm shares at $16.00 (midpoint of the range) and will debut on Thursday.
1
990
#IPO Summary: Calm before the storm?
1
3
1,306
more replies
5/6 🧵 $BMB: The company postponed its IPO, citing market conditions. Bamboo had targeted 35M shares at $18–$20, implying a fully diluted valuation of up to $3.1B. Orion180’s recent performance added pressure.
1
2
355
6/6 Next up: $ACCV and solana:AJnCmqEB88PcbARxeh7SJw4xxhCPA5w4zDg27XzGpump. Accelevation offers exposure to AI data-center infrastructure, while Oura brings its smart-ring health-tracking platform and subscription business to the public markets.
2
416
ADARx Pharmaceuticals Inc. (ADRX) priced 26.3mm shares (upsized from 21.875mm) at $17.00 (high-end of the range) and will debut on Friday. #IPO $ADRX
2
1,544
American Savings Bank, N.A. (ASBH) priced 8.05mm shares (upsized from 7.49mm) at $16.00 (midpoint of the range) and opened at $17.00 for a gain of 6.3% at first trade. #IPO $ASBH
2
1,076
Always-on health intelligence platform, Oura Inc., filed for #IPO. $OURA
1
1
1,313
more replies
They grew Rings Sold from 1.8 million to 3.1 million for the nine months ended June 30, 2025 and 2026, respectively, representing 75% year-over-year growth. We grew Rings Sold from 1.0 million in fiscal 2024 to 2.3 million in fiscal 2025, representing 131% year-over-year growth.
1
381
$OURA to debut on the Nasdaq potentially at the end of September. Link to S-1: sec.gov/Archives/edgar/data/…
374
#IPO Pricing: Lyntris Inc. ($LYNX) priced a downsized offering of 17.0mm shares at $17.50 ($1.50) below the range and will debut on Wednesday.
2
1,268
#IPO Pricings: BlossomHill Therapeutics, Inc. ($BLSM) priced 9.375mm shares (upsized from 7.8mm) at $16.00 (midpoint of the range) and will debut on Friday. Latigo Biotherapeutics, Inc. ($LTGO) priced 19.2mm shares (upsized from 16.0mm) at $18.00 (high-end of the range) and will debut on Friday.
1
5
1,578
#IPO Pricing: Braveheart Bio Inc. ($BRVE) priced 21.25mm shares (upsized from 18.75mm) at $18.00 ($1 Above the $15-$17 range) and will debut on Thursday.
4
1,501
#IPO Pricing: Attovia Therapeutics, Inc. ($ATTO) priced 17.0mm shares at $17.00 (high-end of the range) and will debut on Wednesday.
3
1,430
Load more